Grants and Contributions:
Title:
Validation and Commercialization of Novel Anatomical Models
Agreement Number:
1017891
Agreement Value:
$74,900.00
Agreement Date:
Apr 1, 2024 - Mar 18, 2025
Description:
The Firm has identified an opportunity to validate and commercialize their product line of anatomical models within women’s health. In direct response to market demand, Granville is also seeking to validate two recently developed models, which will expand the existing product line and create new international opportunities to increase revenue. The proposed series of bench test studies in this project are required to validate two recently developed models and to commercialize the complete Granville product line of women's health educational models.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mount Pearl, Newfoundland & Labrador, CA A1N 2Z5
Reference Number:
172-2024-2025-Q1-1017891
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
708322318
Recipient Type:
For-profit organization
Recipient's Legal Name:
Granville Biomedical Inc.
Federal Riding Name:
St. John's South--Mount Pearl
Federal Riding Number:
10007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110